CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-30 | JANNEY DANIEL Director | Grant or award · Stock Option (Right to Buy) | +6,800 | 6,800 | ||
| 2023-06-30 | Gangolli Julian S Director | Grant or award · Stock Option (Right to Buy) | +6,800 | 6,800 | ||
| 2023-06-09 | ORTH ANDREW C. Chief Commercial Officer | Option exercise 10b5-1 | +12,500 | $63.55 | $794K | 12,600 |
| 2023-06-09 | ORTH ANDREW C. Chief Commercial Officer | Sale 10b5-1 | −5,261 | $128.10 | $674K | 7,339 |
| 2023-06-09 | ORTH ANDREW C. Chief Commercial Officer | Sale 10b5-1 | −6,906 | $128.94 | $890K | 433 |
| 2023-06-09 | ORTH ANDREW C. Chief Commercial Officer | Sale 10b5-1 | −333 | $129.70 | $43K | 100 |
| 2023-06-09 | ORTH ANDREW C. Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,500 | 37,500 | ||
| 2023-06-09 | JANNEY DANIEL Director | Sale | −3,935 | $129.29 | $509K | 122,362 |
| 2023-06-09 | JANNEY DANIEL Director | Sale | −5,000 | $128.84 | $644K | 117,362 |
| 2023-06-09 | JANNEY DANIEL Director | Sale | −10,000 | $128.53 | $1.3M | 107,362 |
| 2023-06-08 | JANNEY DANIEL Director | Sale | −4,604 | $127.96 | $589K | 152,758 |
| 2023-06-08 | JANNEY DANIEL Director | Sale | −1,073 | $129.02 | $138K | 151,685 |
| 2023-06-08 | JANNEY DANIEL Director | Sale | −5,388 | $128.73 | $694K | 146,297 |
| 2023-06-08 | JANNEY DANIEL Director | Sale | −5,000 | $127.96 | $640K | 141,297 |
| 2023-06-08 | JANNEY DANIEL Director | Sale | −10,000 | $127.96 | $1.3M | 131,297 |
| 2023-06-08 | JANNEY DANIEL Director | Sale | −5,000 | $127.86 | $639K | 126,297 |
| 2023-05-31 | Krishnan Suma President, R&D | Sale | −20,143 | $115.98 | $2.3M | 1,629,063 |
| 2023-05-31 | Krishnan Suma President, R&D | Sale | −4,557 | $116.86 | $533K | 1,624,506 |
| 2023-05-31 | Krishnan Suma President, R&D | Sale | −300 | $117.57 | $35K | 1,624,206 |
| 2023-05-31 | Krishnan Suma President, R&D | Sale | −18,884 | $116.00 | $2.2M | 1,690,454 |
Page 29 of 42 · 828 trades